Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Azmi Nabulsi Insider Profile
4 Followers
Azmi Nabulsi, COO at Phathom Pharmaceuticals, holds 1.03M shares in Phathom Pharmaceuticals (Ticker: PHAT). Most recently, Azmi Nabulsi Sold $1,118 shares of Phathom Pharmaceuticals on Dec 20, 2024 for an estimated value of 8.94K.
Profitable Transactions
5 out of 5 Profitable Transactions
Average Return
+52.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
COO
Roles that Azmi Nabulsi holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:May 04, 2021 - May 04, 2022
Return:+62.10%
The most profitable trade made by Azmi Nabulsi
Azmi Nabulsi's Trading History
List of latest transactions for each holding click on a transaction to see Azmi Nabulsi's performance on stock
You May Also Like
Azmi Nabulsi insider profile FAQ
What is the percentage of profitable transactions made by Azmi Nabulsi?
The percentage of profitable transactions made by Azmi Nabulsi is 100%.
What is the average return per transaction made by Azmi Nabulsi?
The average return per transaction made by Azmi Nabulsi is 52.10%.
What stocks does Azmi Nabulsi hold?
Azmi Nabulsi holds: PHAT stocks.
What was Azmi Nabulsi’s latest transaction?
Azmi Nabulsi latest transaction was an Informative Sell of $8.94K.
What was Azmi Nabulsi's most profitable transaction?
Azmi Nabulsi’s most profitable transaction was an Informative Sell of PHAT stock on May 4, 2021. The return on the trade was 62.10%.
What is Azmi Nabulsi's role in Phathom Pharmaceuticals?
Azmi Nabulsi's role in Phathom Pharmaceuticals is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.